http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-132019017637-E2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6b8129a4c60441d8ffce326e2cb4d80
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
filingDate 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba17f976e7223199f18e0ee6a107f139
publicationDate 2021-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-132019017637-E2
titleOfInvention drug composition for the treatment of gastroesophageal reflux disease
abstract drug composition for the treatment of gastroesophageal reflux disease is a certificate of addition that provides for the development of a drug formed by the combination of two existing drugs, bethanechol and omeprazole, each with its pre-established concentration; the combination of these 2 drugs will allow the treatment of severe gastroesophageal reflux disease in an efficient manner, in which bethanechol will be used as a prokinetic, as it is a substance analogous to acetylcholine; and omeprazole acts to reduce the formation of hydrochloric acid (hcl) by the parietal cells of the stomach; thus, it will treat the disease and eliminate symptoms and discomforts, such as: heartburn, chronic acid regurgitations, extra-phageal manifestations and the like; offering an improvement in the quality of life of patients undergoing treatment, and also, it presents itself as a new alternative for curing the disease, if it is possible to “buy more time” for the development of children, preventing possible directions for undesirable surgeries.
priorityDate 2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187

Total number of triples: 23.